Does INTERFERON ALFA-2A Cause Focal segmental glomerulosclerosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Focal segmental glomerulosclerosis have been filed in association with INTERFERON ALFA-2A. This represents 0.8% of all adverse event reports for INTERFERON ALFA-2A.
5
Reports of Focal segmental glomerulosclerosis with INTERFERON ALFA-2A
0.8%
of all INTERFERON ALFA-2A reports
0
Deaths
0
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From INTERFERON ALFA-2A?
Of the 5 reports.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON ALFA-2A. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON ALFA-2A Cause?
Fatigue (77)
Anaemia (65)
Drug ineffective (60)
Nausea (46)
Thrombocytopenia (43)
Off label use (42)
Pyrexia (41)
Weight decreased (40)
Depression (39)
Neutropenia (39)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which INTERFERON ALFA-2A Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
INTERFERON ALFA-2A vs INTERFERON ALFA-2A OR INTERFERON ALFA-2B
INTERFERON ALFA-2A vs INTERFERON ALFA-2B
INTERFERON ALFA-2A vs INTERFERON BETA
INTERFERON ALFA-2A vs INTERFERON BETA-1A
INTERFERON ALFA-2A vs INTERFERON BETA-1B